Zobrazeno 1 - 10
of 266
pro vyhledávání: '"R. M. Lozano"'
Autor:
M. Carboneras, C. Iglesias, B. T. Pérez-Maceda, J. A. del Valle, M. C. García-Alonso, M. A. Alobera, C. Clemente, J. C. Rubio, M. L. Escudero, R. M. Lozano
Publikováno v:
Revista de Metalurgia, Vol 47, Iss 3, Pp 212-223 (2011)
En el presente trabajo se ha estudiado el comportamiento frente a la corrosión y la biocompatibilidad in vitro/in vivo de la aleación de magnesio AZ31, cuyas propiedades mecánicas son superiores a los requisitos mecánicos del hueso. La aleación
Externí odkaz:
https://doaj.org/article/1ef4ca0ab374482eab71287df74f2d95
Autor:
Hamad, Hazheer M.1 hanan.baker@koyauniversity.org, Subhi, Hanan T.1
Publikováno v:
Journal of Infection in Developing Countries. 2024 Supplement, Vol. 18, pS56-S66. 20p.
Autor:
Leach, Emily1,2 (AUTHOR) E.M.Leach@soton.ac.uk, Cowley, Emma1 (AUTHOR), Bowen, Catherine1,3 (AUTHOR)
Publikováno v:
Journal of Foot & Ankle Research. Sep2024, Vol. 17 Issue 3, p1-9. 9p.
Autor:
R. M. Lozano, G. Giménez, María Belén Martínez Fernández, Luis García-Fernández, S. Valverde, María Rosa Aguilar, J.L. San Roman
Publikováno v:
Biomacromolecules. 11(7)
New therapeutic strategies for the treatment of neoplastic pathologies and, in particular, metastasis processes are based on the inhibitory effect of angiogenic processes. The present article deals with the design, preparation, and application of new
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fcfa7fc51f91c1509542de29c6567b81
https://pubmed.ncbi.nlm.nih.gov/20527810
https://pubmed.ncbi.nlm.nih.gov/20527810
Publikováno v:
UPCommons. Portal del coneixement obert de la UPC
Universitat Politècnica de Catalunya (UPC)
Universitat Politècnica de Catalunya (UPC)
La inhibición de los promotores de la angiogénesis, como son los factores de crecimiento de fibroblastos, puede ser un nuevo camino para evitar el crecimiento y proliferación de tumores sólidos. El ácido 5-amino-2-naftalensulfónico es un buen i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c69408ccd73b5ed78433b9a991a5b2c5
https://doi.org/10.5821/sibb.v16i1.1768
https://doi.org/10.5821/sibb.v16i1.1768
Publikováno v:
European journal of medical research. 10(9)
Aberrant angiogenesis is essential for the progression of solid tumors and hematological malignancies. Antiangiogenic therapy is one of the most promising approaches to treat such diseases. Dobesilate is an oral agent for treatment of vascular compli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7a514c9eae4f74d084089ad22855980a
https://pubmed.ncbi.nlm.nih.gov/16183547
https://pubmed.ncbi.nlm.nih.gov/16183547
Autor:
J L, de Paz, J, Angulo, J M, Lassaletta, P M, Nieto, M, Redondo-Horcajo, R M, Lozano, G, Giménez-Gallego, M, Martín-Lomas
Publikováno v:
Chembiochem : a European journal of chemical biology. 2(9)
An effective strategy has been designed for the synthesis of oligosaccharides of different sizes structurally related to the regular region of heparin; this is illustrated by the preparation of hexasaccharide 1 and octasaccharide 2. This synthetic st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a985e671fcfa9ab7aa1b35df513016c4
https://pubmed.ncbi.nlm.nih.gov/11828504
https://pubmed.ncbi.nlm.nih.gov/11828504
Publikováno v:
European journal of biochemistry. 260(2)
Kinetoplastid membrane protein-11 (KMP-11) is a major component of the cell surface of kinetoplastids, and acts as a potent B- and T-cell immunogen during Leishmania infection. Here we report that the Leishmania infantum KMP-11 secondary structure ad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b76c1bea3356b1dcaa31702093fd555b
https://pubmed.ncbi.nlm.nih.gov/10095795
https://pubmed.ncbi.nlm.nih.gov/10095795
Publikováno v:
Journal of molecular biology. 281(5)
Recent data show that anti-angiogenesis may provide a promising route to treat cancer. Fibroblast growth factors (FGFs) are powerful angiogenic polypeptides, whose mitogenic activity requires the presence of heparin-like compounds. It has been shown
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::296811bc150b97dae41e748fb9f078f2
https://pubmed.ncbi.nlm.nih.gov/9719643
https://pubmed.ncbi.nlm.nih.gov/9719643
Autor:
Bello-López, Elena1 (AUTHOR), Pérez-Oseguera, Ángeles1 (AUTHOR), Santos, Walter2 (AUTHOR), Cevallos, Miguel Ángel1 (AUTHOR) mac@ccg.unam.mx
Publikováno v:
PLoS ONE. 5/31/2024, Vol. 19 Issue 5, p1-16. 16p.